Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Sevion Therapeutics
About
Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer.
- 11 - 50
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $11.50M
- Industries
- Biopharma,Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1964
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms. The Company’s antibody pipeline is being developed from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, such as multispanning membrane proteins and ion channels that play an important role in multiple diseases. The Company also developed the first protein nanocage system allowing delivery of nucleic acids and other payloads to target cells.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 29, 2010 | Post-IPO Equity | $11.50M | 4 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
Linden Asset Management
|
— | Post-IPO Equity |
Midsummer Capital
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
